S2Medical AB (publ) (STO:S2M)

Market Cap	4.72M -71.4%
Revenue (ttm)	16.13M +9.9%
Net Income	-10.09M
EPS	-0.01
Shares Out	906.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,781,073
Open	0.0046
Previous Close	0.0052
Day's Range	0.0044 - 0.0054
52-Week Range	0.0042 - 0.0179
Beta	2.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2013
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: S2M

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 30, 2026

Data Sources Report a data error